Medicines Formulary

Medicines A–Z

A

Drug name	NICE TAs	Comments
Anoro® Ellipta® 55/22mcg (multi dose dry powder inhaler device)		To be used in line with COPD guidance
Antacid and oxetacaine suspension 150ml		Suspension - specialist use only
Anthelios XL®
Anti-D (Rh0) immunoglobulin
Anti-thymocyte globulin (equine) injection
Anti-thymocyte globulin (rabbit) injection
Anusol cream
Anusol HC ointment
Apalutamide	TA741 - Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer TA740 - Apalutamide with androgen deprivation therapy for treating high-risk hormone-relapsed non-metastatic prostate cancer
Apixaban	Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (TA341)	Specialist initiation for the treatment and secondary prevention of DVT and/or PE - use in line with NICE and supported by RICaD

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.